Partner Content Partner Content Registration opens for SMi’s 3rd annual Injectable Drug Deli... Injectable Drug Delivery Conference returns to London
Partner Content Partner Content Formulation & Drug Delivery Series US Join 250+ pharmaceutical leaders, experts & researchers
Partner Content Partner Content Device advancements to be discussed at the Respiratory Drug ... Device advancements to be discussed
Partner Content Partner Content Key Opinion Leaders to present at the Respiratory Drug Deliv... Respiratory Drug Delivery
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
